2000
Vascular drugs in the new millennium11No competing interests declared.
Frangos S, Chen A, Sumpio B. Vascular drugs in the new millennium11No competing interests declared. Journal Of The American College Of Surgeons 2000, 191: 76-92. PMID: 10898187, DOI: 10.1016/s1072-7515(00)00292-1.Peer-Reviewed Original ResearchAbciximabAnimalsAnistreplaseAntibodies, MonoclonalAnticoagulantsAspirinChondroitin SulfatesClopidogrelDermatan SulfateDrug CombinationsFibrinolytic AgentsHeparin, Low-Molecular-WeightHeparitin SulfateHumansImmunoglobulin Fab FragmentsIntermittent ClaudicationPlatelet Aggregation InhibitorsStreptokinaseTiclopidineVascular DiseasesVenous Thrombosis
1998
Low molecular weight heparins: current use and indications
Quader M, Stump L, Sumpio B. Low molecular weight heparins: current use and indications. Journal Of The American College Of Surgeons 1998, 187: 641-658. PMID: 9849742, DOI: 10.1016/s1072-7515(98)00255-5.Peer-Reviewed Original ResearchMeSH KeywordsAmbulatory CareBlood Coagulation FactorsHeparin, Low-Molecular-WeightHumansPatient AdmissionPulmonary EmbolismThrombophlebitisTreatment OutcomeConceptsUnfractionated heparinPrimary prophylaxisHeart diseaseSurgical proceduresIschemic heart diseaseValvular heart diseaseTreatment of patientsGeneral surgical proceduresAttention of cliniciansOrthopedic surgical proceduresEase of administrationSecondary prophylaxisPostoperative patientsPulmonary embolismThromboembolic complicationsUnstable anginaPredictable anticoagulationSignificant morbidityThromboembolic diseaseOutpatient settingMultiple traumaClinical trialsVascular surgerySimilar complicationsLMWHs